Biosimilars in Oncology - Pricing is a Key Issue for Biosimilars Entering an Increasingly Crowded Market Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thematic Intelligence - Biosimilars in oncology" report has been added to ResearchAndMarkets.com's offering.The report provides an insight into the...

Unlocking the Potential: Investment in R&D Drives Oncology Biosimilars Growth 2023 Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Oncology Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global oncology biosimilars market...

Oncology Biosimilar Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis Pune, India, March 15, 2022 (GLOBE NEWSWIRE) -- The global oncology biosimilar market is poised for rapid growth as patents of expensive biologic drugs are on the verge of expiration. Key insights...

Report [2020-2026] Oncology Biosimilars Market Size, Share, Trends, Growth, Analysis, Competitive Landscape, Revenue, Forecast Pune, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The global Oncology Biosimilars Market is poised for rapid growth as patents of expensive biologic drugs are on the verge of expiration. Key insights in...

Oncology Biosimilars Market to reach US$17,478.2 mn by 2025, globally: Transparency Market Research Albany - NY, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Demand for Affordable Therapies for Cancer Aids Growth Majorly fuelling the growth of oncology biosimilars market is the need to develop...